Shield Therapeutics reports a surge in Accrufer prescriptions and a strengthened balance sheet in Q1 2024, reiterating guidance to turn cashflow positive in H2 2025.
The innovative biopharmaceutical company enjoys a landmark year, with its capital efficient approach and beefed-up management team giving it plenty of firepower to deliver its ambitious development programme.
Good Life Plus hits 30,000 subscribers, attributing the milestone to strategic growth initiatives and enhanced customer satisfaction in the luxury prize draw and rewards sector.
In this interview, CEO Tarek Fadel and CFO Ian Flaherty of Fadel Partners - take me through today's positive FY23 results (Sales up 10% LFL to $14.5m), 31% jump in ARR ($11.4m) & outlook.
Jeremy Skillington, CEO of Poolbeg Pharma (POLB) talks Vox Markets through a landmark year that has seen the innovative biopharma company make huge strides progressing its treatments, opening up new markets, and strengthening its team - all whilst retaining its strong balance sheet thanks to disciplined capital allocation.
In today's edition of Taking Stock, we look at encouraging updates from companies including Eagle Eye Solutions and Induction Healthcare. Meanwhile, Petrofac continues to wrestle with its debt load and the Hipgnosis Songs Fund receives another increased takeover offer.
Vast Resources provides updates on funding agreements with A&T Investments and Mercuria Energy Trading.
Rogue Baron strengthens its premium spirits portfolio and market presence through the acquisition of Eight Vodka, expanding its distillation and distribution assets.
After last week's positive yearend trading update (re FY24 EBITDA almost doubling to £38m on sales up 44% to £225m) - CEO Sandy Chadha of FMCG products group Supreme took me thorough what's been driving the record results and upbeat outlook.
i3 Energy announces record production and strong financial performance in 2023 after successful debt refinancing and strategic growth initiatives for its Canadian operations, alongside commitments to ESG goals and shareholder returns.
Critical Metals is getting busy on the ground in the Democratic Republic of Congo, as ESG work and road upgrades gather pace
European Green Transition cuts its first deal as a listed entity
In today's edition of the show we look at some big-caps with interesting announcements (Anglo American, Sainsbury and Carnival) plus our usual trip through small-cap news including the likes of Record, Loungers and Brickability.
On today's Exchange, I was delighted again to speak to accomplished investor and ex fund manager Graham Neary
In today's edition of Taking Stock we look at a few early-stage companies: Checkit and Skillcast. But we also review Focusrite, Vianet and several more!
Checkit reports 16% growth in recurring revenues, 46% reduction in losses, and a 4% margin improvement in its final results for FY24, reflecting continued momentum and progress towards profitability.
In this interview, Vox Markets speaks to Tim Carrol and Sally McKone, CEO and CFO of Focusrite, about how they’ve steered the music technology group through a tough year which has seen them gain market share in the face of industry-wide supply chain challenges.
In our regular catchup on all things macroeconomic, Singer’s Jamie Constable and Vox Markets’ John Hughman talk about why things might be about to brighten up across the UK economy and stock markets, and how investors should be positioned to take advantage of the recovery.
i3 Energy announces an ambitious 2024 capital budget and production guidance, signaling a strong commitment to growth and shareholder returns.
Top private investor John Rosier returns to Vox Markets to talk us through how he’s responded to a tough 2023 by returning to the quality approach that’s delivered 12% annualised returns since he began reporting on his portfolios via his website https://www.jicuk.com/ a decade ago.